Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$1.55 USD
+0.16 (11.51%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.56 +0.01 (0.65%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Century Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -136.67 | -130.93 | -95.82 | -53.58 | NA |
Depreciation/Amortization & Depletion | 9.15 | 8.74 | 4.05 | 1.49 | NA |
Net Change from Assets/Liabilities | 9.38 | 123.95 | -2.80 | 4.86 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 29.79 | 12.30 | 5.57 | 5.95 | NA |
Net Cash From Operating Activities | -88.35 | 14.05 | -89.00 | -41.27 | NA |
Property & Equipment | -13.74 | -30.60 | -44.97 | -9.83 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -4.72 | NA |
Investments | 74.87 | 17.48 | -253.37 | -8.21 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 61.13 | -13.13 | -298.34 | -22.76 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.52 | 27.16 | 162.15 | 0.00 | NA |
Issuance (Repayment) of Debt | -10.24 | 0.00 | 0.00 | 9.73 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 255.63 | 37.96 | NA |
Net Cash from Financing Activities | -9.73 | 27.16 | 417.77 | 47.69 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -36.94 | 28.08 | 30.43 | -16.34 | NA |
Cash at Beginning of Period | 86.24 | 58.16 | 27.73 | 44.06 | NA |
Cash at End of Period | 49.30 | 86.24 | 58.16 | 27.73 | NA |
Diluted Net EPS | -2.30 | -2.27 | -2.96 | NA | NA |
Fiscal Year End for Century Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -59.27 | -28.06 | -136.67 | -97.28 |
Depreciation/Amortization & Depletion | NA | 4.23 | 2.11 | 9.15 | 9.59 |
Net Change from Assets/Liabilities | NA | -8.33 | -9.05 | 9.38 | 12.29 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 5.79 | 4.75 | 29.79 | 13.28 |
Net Cash From Operating Activities | NA | -57.58 | -30.25 | -88.35 | -62.12 |
Property & Equipment | NA | -0.80 | -0.54 | -13.74 | -12.76 |
Acquisition/ Disposition of Subsidiaries | NA | -9.61 | 0.00 | 0.00 | 0.00 |
Investments | NA | -11.91 | 12.08 | 74.87 | 55.29 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -22.32 | 11.54 | 61.13 | 42.53 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.47 | 0.37 | 0.52 | 0.87 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | -10.24 | -10.24 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 74.42 | 17.83 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 74.89 | 18.20 | -9.73 | -9.37 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -5.01 | -0.51 | -36.94 | -28.96 |
Cash at Beginning of Period | NA | 49.30 | 49.30 | 86.24 | 86.24 |
Cash at End of Period | NA | 44.29 | 48.79 | 49.30 | 57.29 |
Diluted Net EPS | NA | -0.38 | -0.45 | -0.66 | -0.55 |